As a mage, I just want to pursue the truth

Chapter 180 You are too skilled (4000)

Cheng Gang was fed up with the inexplicable sense of superiority of foreign companies.

He chose to return to China after graduating with a Ph.D. from America because the hidden ceiling for Chinese in American companies was too thick and difficult to break.

Therefore, Cheng Gang has never had a good impression of European and American companies.

This time, the public's inexplicable sense of superiority made him even more unhappy.

Finally, I couldn't help but say a few words back.

The other party obviously did not expect Cheng Gang's reaction, and the two sides parted unhappily.

Volkswagen has a huge influence in the country.

The joint ventures SAIC Volkswagen and FAW Volkswagen's upstream and downstream industrial chains have a combined impact on more than 200,000 jobs.

(Estimated based on the number of Volkswagen employees at FAW-Volkswagen North China Base.)
Not to mention that this year marks the 30th anniversary of Volkswagen's entry into the Chinese market and it has been operating in China's political and business circles for 30 years.

Soon, Kechuang Bio came under pressure from Chinese officials.

Tesla's energy is far inferior to Volkswagen's.

As a mature manager, Cheng Gang would not let his emotions affect his normal work. He immediately reported the situation to Zheng Li:
"A certain domestic department told me that they hope we can treat foreign and domestic automakers equally."

(Here I can only imply that Cheng Gang’s remarks must have been very straightforward, otherwise Zheng Li, an alien, would not have understood the twists and turns involved.)

After Cheng Gang finished explaining in detail, Zheng Li was puzzled:

“Doesn’t BYD supply electric vehicles to SAIC and FAW’s wholly-owned electric vehicle brands?”

Cheng Gang said helplessly: "That's right, but the sales of joint venture new energy vehicle brands have been seriously affected."

Zheng Li continued to ask: "China's electric car brands now have technological advantages. Isn't this an opportunity to overtake others?"

"It's not that we don't supply to foreign manufacturers, but the production cycle of graphene manufacturing machines is so long. Is there any problem in giving priority to domestic companies?"

Cheng Gang nodded: "No problem."

“But not everyone thinks that way.”

"They said we refused to provide Tesla with super lithium battery technology, and they fully understood and supported it."

"But we cannot discriminate against foreign manufacturers with whom we have cooperated for many years."

“If Kechuang Biotechnology’s production capacity is insufficient, we can also license the graphene multilayer structure manufacturing technology.”

Cheng Gang seemed to have something to hide. After a pause, he decided to tell Zheng Li the truth:

"Mr. Zheng, in fact, the higher-ups may not really want to help Volkswagen obtain technology authorization as simple as that."

"People from various channels have told me that the proportion of state-owned assets in Kechuang Bio is too low. This incident is actually a different kind of warning."

During its Series B investment, Sinovation Biopharma gave Bocom International a 5% stake.

After listing, 10% of the shares were publicly issued.

Even if China's state-owned capital took all these shares, it would only be 15%.

This is obviously not enough for such an important company as Kechuang Bio.

"I think you must have heard the news in Lion City."

Zheng Li sighed: "Okay, I got it."

“Can other state-owned brands stop this?”

Cheng Gang shook his head: "Automakers are undoubtedly the beneficiaries in this matter, but the official influence of new car manufacturers such as Weilai, Xiaopeng, and Ideal is too low."

"At best they offer advice, but it doesn't have much effect."

"And the battery manufacturer actually has some complaints about us."

"If we don't lock in orders to domestic automakers in advance, they can just set their own prices and supply according to demand, and the highest bidder wins."

“You can get the biggest share of the profits.”

"But now the orders have been signed before the production of super lithium batteries. In this market where supply is far less than demand and the supply-demand relationship is abnormal, they cannot obtain excess profits."

"So there's no real party that can help relieve the pressure on us in this matter."

Zheng Li nodded: "Okay, you go and contact them, we can increase the number of shares appropriately to resolve this matter."

In a sense, Zheng Li still wants to keep his current identity and still wants to play within the rules, so he has no choice but to do this.

Because even if this compromise is made, battery manufacturers will be allowed to play freely.

Then the technology alliance built by Ke Chuang Bio is useless. If the leader is so easy to compromise, where is your voice?
In addition, appropriately releasing shares to state-owned assets is, in a sense, a once-and-for-all solution.

Similar incidents will not happen again in the future.

Zheng Li’s bottom line is to maintain at least 51% of the shares and have controlling rights.

Absolute control has long been lost.

Cheng Gang saw that Zheng Li looked unhappy, so he comforted him, "Director Zheng, people should learn to compromise when they should."

"It is a good thing to appropriately increase the proportion of state-owned assets. We can get more support from the official level."

"You can also cash out part of your shares and start a new business in Singapore, or set up an offshore trust fund."

"You don't have to issue additional shares, you can also transfer shares. Even if you only transfer 5% of your shares to the state-owned assets, using this part of the money to set up a trust will be enough to guarantee the wealth of your descendants for two hundred years."

Many wealthy people in China like to go to Hong Kong to set up trusts.

Many top wealthy people in Shenhai go to Hong Kong to set up trusts, and ordinary middle-class people go to Hong Kong to buy commercial pension insurance.

"Announcement of Kechuang Biotechnology Co., Ltd. on the progress of planning share transfer changes and suspension of trading"

"LI ZHEN, the controlling shareholder and actual controller of Kechuang Biotechnology Co., Ltd. (hereinafter referred to as "Kechuang Biotechnology")
(Zheng Li) (Chairman) is planning to acquire shares in the near future

Transfer matters.

The company's stock (stock name: Kechuang Biotechnology, stock code: ******) will be traded on January 2024, 1.
Trading will be suspended from the opening of the market on Wednesday morning.

Kechuang Bio's trading was suspended, and the major shareholder's private transfer of non-circulating restricted shares caused an uproar in the investment circle.

Because the share price of Kechuang Bio has been rising steadily, especially after the enthusiastic response to the brain-computer interface VR after its listing, Zheng Li has no reason to transfer the company.

"Is Kechuang Biotechnology going to go bankrupt?"

"You're overthinking it. For such an expensive company, how could the transferee not do due diligence when transferring shares?"

"It may be that Zheng Shen simply wanted to cash out part of the shares, but the non-circulating shares are difficult to list and trade, so this is the only way."

"As long as Zheng Shen is still the chairman of Sinovation Biotech, I will continue to hold shares in Sinovation Biotech."

"Let's wait and see the annual report. The transferee has not yet been announced. It is possible that the transferee can help the development of Kechuang Bio in some aspects."

The stock bar of Kechuang Bio is very lively. As the company with the highest market value among listed companies in China, the stock bar of Kechuang Bio has always been very lively.

It's just that the sudden announcement made the place more lively.

While investors are still guessing, investment institutions have already received the news.

With such a large plate involved and such a high capital flow, it is obviously impossible to hide it from the top investment institutions.

"I really didn't expect Zheng Li to transfer his shares at this time. Not everyone has the courage to sell shares during a rising period."

"Zheng Li is not an ordinary person. I just regret that we are not the assignee. Kechuang Biotechnology is such a good company, but we only have 5% of the shares." "There is no other way. The assignee is Huaguo Investment. What can we use in China to compete with them?"

When China Investment Co., Ltd. was established in 07, its registered capital was as high as billion euros.

One of the largest sovereign wealth funds in the world, known for its lavish financial resources.

(The chairman of my former company later became the chairman of Huaguo Investment Group)

"We can only regret that we didn't expect Zheng Li to be willing to sell his shares at this time. If we had talked to Zheng Li in advance, maybe there would have been a chance."

"Then have you ever thought that Huaguo Investment Co., Ltd. has taken out bargaining chips that we can't?"

"For this level of transaction, money is secondary. It is indeed possible that it is a bargaining chip that we cannot afford. Kechuang Biotechnology's position is now more stable."

“And you regret that we are not the transferee this time, so we cannot seize this opportunity.

It’s better to regret that when Kechuang Biopharma raised its B round of venture capital, we only got 5% of the shares.

It would have been great if I had taken 10% of the shares at that time."

Li Shuyao was also indirectly affected. After getting off work at 10pm, she called Li Miaomiao:

"Miao Miao, this is too difficult. Why did Zheng Li suddenly transfer his shares?"

After Li Miaomiao turned on the speaker, she washed up and said, "The company needs to develop, so the shares are being transferred."

Li Shuyao asked: "Then do you know who the transferee is?"

"My boss asked me to write a research report on the transfer of shares by the controlling shareholder of Kechuang Biotechnology, and it also needs to be distinctive."

"The problem is that there are so many research reports on Kechuang Biotechnology, how can we write a distinctive one?"

"There is only one announcement now, but we don't know the transferee, share transfer amount and price."

"It's really difficult for me to write a research report with novel ideas under such circumstances."

"Sometimes, some of the leaders' requests make you wonder if they are living in outer space. They are not down to earth at all."

After Li Shuyao finished her complaints, Li Miaomiao said slowly:
"The transferee is also a state-owned enterprise with a Chinese prefix. I guess your leader must have received the news. This is a test for you."

Li Shuyao suddenly realized: "The word 'Zhong' in the beginning? Could it be China International Capital Corporation?"

"It shouldn't be. If it was CICC, with this level of good news, the gods who got the news should have pulled out a large-volume positive line for CICC long ago."

Li Miaomiao thought about it but couldn't figure it out. There are too many state-owned enterprises, and many of them are powerful.

She couldn't guess which one it was: "It shouldn't be a listed central enterprise with a Chinese character in its name, it should be a wholly-owned central enterprise."

"No wonder, I know how to write the research report."

"Starting from the diversified shareholder composition, the Chinese government is optimistic about the future development prospects of Sinovation Biotechnology."

"It is written around the further enhancement of the strategic position of Kechuang Biotechnology."

Just give it a random name, and then replace it with one click when the specific announcement comes out.

The most important thing is that the research report should be issued as soon as possible and should be relevant to the facts. The research reports of securities firms have also been in great demand in recent years.

If it wasn't so competitive, there wouldn't be any need for securities analysts to use the five elements to interpret the A-share market.

But Big A is indeed metaphysics.

Li Miaomiao laughed and said, "Haha, I feel bad for the way you write research reports so skillfully."

Li Shuyao smiled bitterly: "This is how miserable investment bankers are. Writing and reading research reports are basic skills."

Experienced investment bankers know exactly how much water there is in a research report, which parts are copied and pasted, and which brokerage firms' research reports actually have valuable information.

Li Shuyao asked, "You came back from Lion City a few days ago? Did you and Zheng Li spend a few days together?"

Li Miaomiao was already used to Li Shuyao's teasing: "I have something at work that requires Zheng Li's signature and fingerprint."

Li Shuyao seemed to have remembered something and asked, "Have you considered how to manage the money from Zheng Shen's share transfer this time?"

“Can we put a small part of it into CICC? Although CICC’s wealth management scale is not large, it is small but fine.”

"If Zheng Shen has this intention, I will switch to the front end overnight. This small goal will be enough for me to live on for ten years."

Li Miaomiao: "This is not something I can decide. Zheng Li has his own plans."

"I didn't ask."

Li Shuyao was curious: "So what do you usually talk about when you meet? Or work?"

Li Miaomiao thought for a moment and replied, "Most of the time we talk about work, and occasionally we talk about other things."

Li Shuyao: "What a boring person~"

Research on Bill is ongoing in a secret laboratory in America.

“Physically, Bill is indeed lacking something in his body.

He still has reward hormones and intimacy hormones in his body.

But he really couldn't feel any positive emotions.

The psychologist's emotion regulation intervention had no effect.

The neurotransmitter he lacks in his body causes the GABAergic neuron mechanism to not function properly.

This includes the SWELL1 channel in astrocytes that regulates synaptic transmission and does not function properly."

"Of course I know that psychiatrists are useless. The big shots have hired so many psychiatrists but none of them have helped. Please just tell me your conclusion."

“Based on the current results, the loss of pure neurotransmitters may only be part of the cause of Bill’s current situation.

We suspect that Bill has a missing soul, which means that Merlin's attack is not only physical, but also spiritual."

"Okay, I know you don't have any evidence when it comes to the soul level, and you can't just shoot Bill.

I don't expect the reverse technology to be cracked in a short time, and the project will continue to move forward until there is progress.

Write reports to your superiors based on the actual situation and don't have too high expectations of the bigwigs.

Otherwise, if we fail to meet their expectations, we will all be doomed.

Lower their expectations.”

"Okay. In addition, according to the results of the investigation of William's body, his brain structure has undergone significant changes from the normal brain structure, and is also different from the internal structure of Witten's brain.

We speculate that the magic brain that Merlin injected into William was a completely new type."

“That’s normal. Merlin has different types of magic brains. We had expected that.

In a sense, this is a genetic drug, and it is normal for there to be many different types of drugs.”

"There has also been no progress in reverse engineering the Demon Brain, and we have no idea at the moment."

"I can totally understand that magic is something beyond our understanding."

After the American side and the European Union jointly examined William's body, neither side found anything valuable.

All that can be confirmed is that William was controlled remotely by Merlin, and the means of control are only speculation.

The Europa League obtained the magic wand, and after letting Pierre experiment with it, they found that it also had no effect in increasing magic power.

(End of this chapter)